Digital Health Startups
6,443 companies tagged Digital Health, with their investors and founders.
AiD Medical develops health technologies, including AI and machine learning tools, aimed at improving health outcomes across the Global South.
1 investor
AI Medica provides evidence-based EHR automation software for physicians to optimize patient coding, documentation, and reimbursement. The platform integrates with existing EHR systems to support value-based care delivery and improve clinical outcomes.
1 investor
AI-Stroke develops AI-driven medical software for the diagnosis and management of stroke, analyzing neurovascular brain imaging to support clinicians' treatment decisions. The company serves stroke and cerebrovascular care providers in the healthcare and medical device industry.
1 investor
AI-MD uses camera-based rPPG biomarker detection to read signals like blood flow, oxygenation, pulse, and stress response from a facial scan, then combines these with lifestyle questions to generate personalized supplement recommendations. It serves consumers seeking data-driven wellness insights and matches their biomarker data to supplement formulations from various wellness brands.
1 investor
AIBTRUST is a University of Osaka-originated venture company based in Japan working in the artificial intelligence field. The page provides corporate information and executive background but limited detail on specific products.
1 investor
Aictive develops AI-based solutions to prevent and treat musculoskeletal disorders (MSK), including ergonomic evaluations, personalized recommendations, and remote physical therapy where AI checks patients' exercises in real time. It uses hybrid care models combining remote follow-ups with in-person visits, aimed at reducing treatment costs and workplace injury claims for policyholders and employers.
1 investor
AID:Tech delivers international aid and payments using blockchain technology, with a focus on digital identity. The company enables individuals to own and control their self-sovereign identities.
1 investor
Aidexpress provides personalized in-home care and support services—including daily living assistance, nursing and health care, housekeeping, wellness care, and specialized professionals—matching caregivers to clients such as seniors, people with reduced mobility or cognitive disorders, patients in convalescence, families, veterans, and those needing palliative care. It operates across Quebec and Ontario, Canada.
1 investor
AidRx embeds an AI and clinical-pharmacist workflow into clinics to manage patient medications between visits, handling refill requests, medication questions, and follow-up through the clinic's existing phone, SMS, and care outreach channels. It logs clinical decisions to the clinic's EHR and bills under value-based care codes, aiming to help clinics support patients and generate revenue without adding staff.
1 investor
Advanced Image Enhancement (AIE) develops image enhancement algorithms for radiology that improve the clarity and detail of subtle abnormalities in medical images. Its software is positioned as a complement to AI applications in radiology.
1 investor
AIG Hospitals is a healthcare provider that combines patient care with clinical research and academic training for medical professionals. It emphasizes evidence-based, technology-supported treatment across its hospital ecosystem.
1 investor
AIKON Health develops a wearable heart failure monitoring device paired with digital health software that supports cardiologists and nurses in medication titration and continuous monitoring of heart failure patients. The system provides clinically validated digital biomarkers and integrates with hospital information and remote patient monitoring systems to reduce hospital readmissions.
1 investor
A company operating an online-and-offline specialty drug service platform focused on high-incidence cancers, offering digital pharmacy benefit management, traditional Chinese medicine diagnosis and treatment, family doctor and home care services, and full-cycle health management. It also provides consulting and pricing to help insurers control costs and applies AI and big-data models to personalized medical services.
1 investor
Aimé is an AI assistant for behavioral-health clinicians that works inside existing web-based EHRs, calendars, inboxes, and payer portals via a browser extension to draft clinical notes, update charts, schedule follow-ups, reply to messages, and prepare payer documentation. It serves psychiatrists, therapists, and group practices, keeping every action under clinician approval with HIPAA/BAA handling and audit receipts.
1 investor
AI Optics develops AI software and portable imaging hardware for eye disease screening, designed to move diagnosis out of specialist offices and into point-of-care settings such as primary care and retail health clinics. It targets healthcare professionals seeking earlier, faster eye disease diagnosis.
1 investor
Aira offers remote, on-demand visual and American Sign Language interpreting through video, connecting blind, low-vision, Deaf, and hard-of-hearing users to professional interpreters via its Aira Explorer and Aira ASL apps. Organizations partner with Aira to provide the services for free to their employees, students, or customers, and the services are available at Access Partner locations worldwide, with ASL interpreting offered across North America.
1 investor
AIRA is a platform that uses AI to support clinical development decision-making and study design for pharmaceutical and biotech companies. The company addresses inefficiencies in the drug development process by providing a unified, regulatory-grade system to help clinical teams design therapies faster and more safely.
1 investor
Airalux develops a digital therapeutic spirometer for post-surgery breathing exercises, providing automatic adherence and performance tracking plus on-device real-time inhalation feedback. It serves inpatient surgical patients and healthcare providers such as nurses, respiratory therapists, surgeons, and hospital systems to reduce postoperative pulmonary complications.
1 investor
AirCaps manufactures lightweight smart glasses that display real-time captions, translate conversations across 60+ languages, and provide AI-powered meeting intelligence for users. The product is designed for Deaf and Hard of Hearing communities, international travelers, and business professionals.
1 investor
AirStrip provides mobile and web applications that consolidate clinical data from EMRs, in-room monitors, and medical devices into a single view, giving clinicians remote access to patient waveforms, ECGs, and vital signs. Its tools support cardiac monitoring, maternal-fetal monitoring, alarm management, and digitized clinical protocols for hospital care teams.
1 investor
Airway Therapeutics is a biotech company developing inhaled therapeutics for inflammatory and infectious lung diseases, including programs targeting bronchopulmonary dysplasia, acute respiratory distress syndrome, and pulmonary fibrosis.
1 investor
AISAP develops an FDA-cleared, AI-powered platform for point-of-care ultrasound (POCUS) that delivers expert-level diagnostic results at the bedside. Its tools support clinicians in shortening diagnosis time, reducing length of stay, detecting structural heart disease early, and avoiding unnecessary patient transfers.
1 investor
AIS Healthcare provides in-home and infusion-center immunoglobulin and Alpha-1 therapies through its Advanced Infusion Care division, and patient-specific compounded medications for individuals with implanted intrathecal infusion pumps through its Targeted Drug Delivery division. It serves patients with complex conditions and their providers across the United States, operating nursing services and 503A compounding pharmacies.
1 investor
Aisel builds a clinical operating system for private psychiatric clinics, using six coordinated AI agents to handle intake screening, in-session listening and documentation, billing code derivation, and bidirectional EHR sync. Its platform supports heavy psychiatric documents such as court reports and Mental Health Act work by citing statements to source records, with GDPR-compliant infrastructure and UK/EU data residency.
1 investor









